Literature DB >> 22422882

Cutting edge: protein phosphatase 2A confers susceptibility to autoimmune disease through an IL-17-dependent mechanism.

José C Crispín1, Sokratis A Apostolidis, Florencia Rosetti, Marton Keszei, Ninghai Wang, Cox Terhorst, Tanya N Mayadas, George C Tsokos.   

Abstract

The contribution of individual molecular aberrations to the pathogenesis of systemic lupus erythematosus (SLE), an autoimmune disease that affects multiple organs, is often difficult to evaluate because of the presence of abundant confounding factors. To assess the effect of increased expression of the phosphatase protein phosphatase 2A (PP2A) in T cells, as recorded in SLE patients, we generated a transgenic mouse that overexpresses the PP2Ac subunit in T cells. The transgenic mouse displays a heightened susceptibility to immune-mediated glomerulonephritis in the absence of other immune defects. CD4(+) T cells produce increased amounts of IL-17 while the number of neutrophils in the peripheral blood is increased. IL-17 neutralization abrogated the development of glomerulonephritis. We conclude that increased PP2Ac expression participates in SLE pathogenesis by promoting inflammation through unchecked IL-17 production and facilitating the development of end-organ damage.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22422882      PMCID: PMC3324672          DOI: 10.4049/jimmunol.1200143

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

Review 1.  Systemic lupus erythematosus.

Authors:  George C Tsokos
Journal:  N Engl J Med       Date:  2011-12-01       Impact factor: 91.245

2.  Ikaros enforces the costimulatory requirement for IL2 gene expression and is required for anergy induction in CD4+ T lymphocytes.

Authors:  Rajan M Thomas; Neelanjana Chunder; Chunxia Chen; Sarah E Umetsu; Susan Winandy; Andrew D Wells
Journal:  J Immunol       Date:  2007-12-01       Impact factor: 5.422

3.  Protein phosphatase 2A is a negative regulator of IL-2 production in patients with systemic lupus erythematosus.

Authors:  Christina G Katsiari; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Clin Invest       Date:  2005-10-13       Impact factor: 14.808

4.  Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys.

Authors:  José C Crispín; Mohamed Oukka; George Bayliss; Robert A Cohen; Christine A Van Beek; Isaac E Stillman; Vasileios C Kyttaris; Yuang-Taung Juang; George C Tsokos
Journal:  J Immunol       Date:  2008-12-15       Impact factor: 5.422

5.  Complement activation and vascular injury in systemic lupus erythematosus.

Authors:  S Abramson; H M Belmont; P Hopkins; J Buyon; R Winchester; G Weissmann
Journal:  J Rheumatol Suppl       Date:  1987-06

6.  Human neutrophil Fcgamma receptors initiate and play specialized nonredundant roles in antibody-mediated inflammatory diseases.

Authors:  Naotake Tsuboi; Kenichi Asano; Michael Lauterbach; Tanya N Mayadas
Journal:  Immunity       Date:  2008-06       Impact factor: 31.745

7.  Improved version of a human CD2 minigene based vector for T cell-specific expression in transgenic mice.

Authors:  T Zhumabekov; P Corbella; M Tolaini; D Kioussis
Journal:  J Immunol Methods       Date:  1995-09-11       Impact factor: 2.303

Review 8.  Experimental anti-GBM disease as a tool for studying spontaneous lupus nephritis.

Authors:  Yuyang Fu; Yong Du; Chandra Mohan
Journal:  Clin Immunol       Date:  2007-08       Impact factor: 3.969

9.  Cell-type-specific epigenetic marking of the IL2 gene at a distal cis-regulatory region in competent, nontranscribing T-cells.

Authors:  Satoko Adachi; Ellen V Rothenberg
Journal:  Nucleic Acids Res       Date:  2005-06-03       Impact factor: 16.971

10.  Interferon and granulopoiesis signatures in systemic lupus erythematosus blood.

Authors:  Lynda Bennett; A Karolina Palucka; Edsel Arce; Victoria Cantrell; Josef Borvak; Jacques Banchereau; Virginia Pascual
Journal:  J Exp Med       Date:  2003-03-17       Impact factor: 14.307

View more
  30 in total

1.  Serine/threonine phosphatase PP2A is essential for optimal B cell function.

Authors:  Esra Meidan; Hao Li; Wenliang Pan; Michihito Kono; Shuilian Yu; Vasileios C Kyttaris; Christina Ioannidis; Noe Rodriguez Rodriguez; Jose C Crispin; Sokratis A Apostolidis; Pui Lee; John Manis; Amir Sharabi; Maria G Tsokos; George C Tsokos
Journal:  JCI Insight       Date:  2020-03-12

Review 2.  Genetics and pathogenesis of systemic lupus erythematosus and lupus nephritis.

Authors:  Chandra Mohan; Chaim Putterman
Journal:  Nat Rev Nephrol       Date:  2015-03-31       Impact factor: 28.314

Review 3.  T cells and IL-17 in lupus nephritis.

Authors:  Tomohiro Koga; Kunihiro Ichinose; George C Tsokos
Journal:  Clin Immunol       Date:  2016-04-21       Impact factor: 3.969

4.  Retinoic acid modulates interferon-γ production by hepatic natural killer T cells via phosphatase 2A and the extracellular signal-regulated kinase pathway.

Authors:  Heng-Kwei Chang; Wu-Shiun Hou
Journal:  J Interferon Cytokine Res       Date:  2014-10-24       Impact factor: 2.607

5.  Protein phosphatase 2A B55β limits CD8+ T cell lifespan following cytokine withdrawal.

Authors:  Noé Rodríguez-Rodríguez; Iris K Madera-Salcedo; J Alejandro Cisneros-Segura; H Benjamín García-González; Sokratis A Apostolidis; Abril Saint-Martin; Marcela Esquivel-Velázquez; Tran Nguyen; Dámaris P Romero-Rodríguez; George C Tsokos; Jorge Alcocer-Varela; Florencia Rosetti; José C Crispín
Journal:  J Clin Invest       Date:  2020-11-02       Impact factor: 14.808

Review 6.  T cells and autoimmune kidney disease.

Authors:  Abel Suárez-Fueyo; Sean J Bradley; David Klatzmann; George C Tsokos
Journal:  Nat Rev Nephrol       Date:  2017-03-13       Impact factor: 28.314

Review 7.  Autoimmune disease in the epigenetic era: how has epigenetics changed our understanding of disease and how can we expect the field to evolve?

Authors:  Matlock A Jeffries; Amr H Sawalha
Journal:  Expert Rev Clin Immunol       Date:  2015-01       Impact factor: 4.473

8.  The glutathione peroxidase 1-protein tyrosine phosphatase 1B-protein phosphatase 2A axis. A key determinant of airway inflammation and alveolar destruction.

Authors:  Patrick Geraghty; Andrew A Hardigan; Alison M Wallace; Oleg Mirochnitchenko; Jincy Thankachen; Leo Arellanos; Victor Thompson; Jeanine M D'Armiento; Robert F Foronjy
Journal:  Am J Respir Cell Mol Biol       Date:  2013-11       Impact factor: 6.914

9.  Inhibition of SHP2 ameliorates the pathogenesis of systemic lupus erythematosus.

Authors:  Jianxun Wang; Masayuki Mizui; Li-Fan Zeng; Roderick Bronson; Michele Finnell; Cox Terhorst; Vasileios C Kyttaris; George C Tsokos; Zhong-Yin Zhang; Maria I Kontaridis
Journal:  J Clin Invest       Date:  2016-05-16       Impact factor: 14.808

10.  Calcium/Calmodulin-Dependent Kinase IV Facilitates the Recruitment of Interleukin-17-Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell-Driven Inflammatory Diseases.

Authors:  Tomohiro Koga; Kotaro Otomo; Masayuki Mizui; Nobuya Yoshida; Masataka Umeda; Kunihiro Ichinose; Atsushi Kawakami; George C Tsokos
Journal:  Arthritis Rheumatol       Date:  2016-08       Impact factor: 10.995

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.